Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application.
Afsaneh SadremomtazAmeena M AliForoozan JouyandehSaeed BalalaieRazieh NavariSylvain BroussyKamran MansouriMatthew R GrovesS Mohsen AsghariPublished in: Signal transduction and targeted therapy (2020)